Brazilian regulator says Bharat Biotech’s Covaxin manufacturing facility fails to meet GMP standards – The Indian Express

Reacting to it, the Hyderabad-based vaccine maker said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is still active. Read More